INTELLECTUAL PROPERTY LICENSING RIGHTS (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|---|
Oct. 12, 2018 |
Aug. 20, 2018 |
Jun. 30, 2021 |
Jun. 30, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
|
Naltrexone Implant Formulation [Member] | Trinity Compound Solutions [Member] | ||||||
Cash paid for acquisition | $ 10,000 | |||||
Aggregate purchase price, Shares | 20,000 | |||||
Estimated useful lives | 5 years | |||||
Aggregate purchase price, value | $ 236,000 | |||||
Intellectual Property [Member] | ||||||
Amortization expense | $ 11,790 | $ 11,790 | $ 23,580 | $ 23,580 | ||
Accumulated amortization | 82,730 | 82,730 | ||||
Patents [Member] | ||||||
Amortization expense | 295 | $ 292 | 589 | $ 584 | ||
Accumulated amortization | $ 11,974 | $ 11,974 | ||||
Six patent families [Member] | ||||||
Estimated useful lives | 13 years | |||||
Patent acquired cost | $ 15,200 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The net cash inflow or outflow associated with the aggregate amount of adjustment to the purchase price of a previous acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|